A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat.
Fosinopril has been studied across 18 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🔥 Metabolic, 🦴 Bone & Joint, 🏋️ Muscle & Hypertrophy. The primary research focus is ❤️ Cardiovascular with 60% of studies addressing this area.
The following compounds share molecular targets with Fosinopril, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Fosinopril is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.